Ally Bridge Group (Ny) LLC Cyteir Therapeutics, Inc. Transaction History

Ally Bridge Group (Ny) LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.39 - $10.51 $1.08 Million - $3.36 Million	-319,538 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$14.57 - $21.86 $4.48 Million - $6.72 Million	-307,305 Reduced 49.02%	319,538 $5.61 Million
Q2 2021 Aug 16, 2021	BUY	$16.8 - $21.4 $10.5 Million - $13.4 Million	626,843 New	626,843 $13.4 Million

2.47M

Ticker CYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,413,400
Market Cap $107M
Description
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.